Clinical Trials Browser

NCT05311618 2024-04-01

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Clinical Trials

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer

MDPK67b in Patients With Prostate Cancer

CAT_PB

Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer

Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer

225AcPSMAI&T

Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg

WEE1

MICROBIOME

To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers

Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour

A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations

PSA

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients

Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer

ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes

Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination

Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET

Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer

MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

SU006668 in Treating Patients With Advanced Solid Tumors

Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

FP253-GDEPT

Investigative Study of the Role of Focal Therapy for Prostate Cancer Treatment

Far Infrared Radiation Treatment for Prostate Cancer

CYT-500

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA